CaroSpir is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corp.. The primary component is Spironolactone.
| Product ID | 17856-0120_16683cbd-f833-40d0-ae1b-6526c06f6276 |
| NDC | 17856-0120 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CaroSpir |
| Generic Name | Carospir |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-08-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209478 |
| Labeler Name | ATLANTIC BIOLOGICALS CORP. |
| Substance Name | SPIRONOLACTONE |
| Active Ingredient Strength | 25 mg/5mL |
| Pharm Classes | Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-05-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209478 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-20 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-05-20 |
| Ingredient | Strength |
|---|---|
| SPIRONOLACTONE | 25 mg/5mL |
| SPL SET ID: | 07504afc-f0b6-40f6-8719-cd1c3e67fc35 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 17856-0120 | CaroSpir | CaroSpir |
| 46287-020 | CaroSpir | CaroSpir |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAROSPIR 86418628 5365294 Live/Registered |
CMP Development, LLC 2014-10-08 |